CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced a change in the Company’s presentation time at the at Aegis 2014 Healthcare & Technology Conference. President and CEO Steven A. Kriegsman and Vice President of Business Development David Haen will present on Friday, September 12th at 10:45am Pacific Time. CytRx Corporation (NASDAQ:CYTR) belongs to Healthcare sector. weekly performance is 5.72%. On last trading day company shares ended up $3.51. CytRx Corporation (NASDAQ:CYTR) distance from 50-day simple moving average (SMA50) is 1.31%.
LipoScience (NASDAQ:LPDX) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by $0.03. On average, analysts predict that LipoScience will post $-0.82 earnings per share for the current fiscal year. LipoScience, Inc. (NASDAQ:LPDX) shares advanced 7.14% in last trading session and ended the day at $3.30. LPDX Gross Margin is 77.60% and its return on assets is -18.30%. LipoScience, Inc. (NASDAQ:LPDX) quarterly performance is 0.61%.
On 2 Sep 2014 SIndia Fund, Inc. (NYSE:IFN) a closed-end equity fund, announced today its performance data and portfolio composition as of July 31, 2014. On 08 September, India Fund, Inc. (NYSE:IFN) shares advanced 0.87% and was closed at $27.68. IFN EPS growth in last 5 year was 14.90%. India Fund, Inc. (NYSE:IFN) year to date (YTD) performance is 38.40%.
FreeSeas Inc (NASDAQ:FREE) regained compliance with NASDAQ’s $2.5 million stockholders equity’ rule on Aug. 14th. Since that time, the stock has fallen twenty cents. FreeSeas Inc. (NASDAQ:FREE) ended the last trading day at $0.47. Company weekly volatility is calculated as 16.03%and price to cash ratio as 2.20. FreeSeas Inc. (NASDAQ:FREE) showed a weekly performance of -19.83%.
On 19 Aug 2014 Enventis Corporation (NASDAQ:ENVE), announced it has established a record date and a meeting date for a special meeting of its shareholders to consider and vote upon a proposal to adopt the previously announced merger agreement, dated as of June 29, 2014, with Consolidated Communications Holdings, Inc. Enventis Corporation (NASDAQ:ENVE) shares advanced 0.68% in last trading session and ended the day on $17.88. ENVE Gross Margin is 41.20% and its return on assets is 2.90%. Enventis Corporation (NASDAQ:ENVE) quarterly performance is 30.13%.